Assessment of the Natural Anticoagulant Profile in Patients with COVID-19.

Assessment of Coagulation Profile in Adults Vaccinated Against SARS‐CoV‐2 (COVID-19) in Qena Governorate

OUTCOME OF CLINICAL PRESENTATIONS AND ABNORMAL COAGULATION PARAMETERS IN COVID-19 PATIENTS

Assessment of Anticardiolipin antibodies, Circulating Lupus anticoagulant, Protein C, Protein S, Antithrombin III &Activated Protein C Resistance and Their Relation to Thomboembo

Study of Plasminogen activator inhibitor-1 (PAI-1) in hospitalized COVID-19 patients

Hematological and Immunological Laboratory findings among COVID 19 Patients

Coagulopathy in COVID-19 from Pathogenesis until Treatment: A systemic Review

COVID 19 associated coagulopathy

Evaluation of Some Biochemical and Hematological Parameters in COVID-19 Patients and its Relation to Severity

Coagulopathy with COVID19 and Tyrosine Kinase Receptor Tie 2: Review Article